No variants were significantly associated with breast cancer risk in UKBiobank after correction for multiple testing, but variants in BICD2 (p = 0.03) and TPPP2 (p = 0.02, OR = 1.95) were independently significant. This evidence concerns the gene TPPP2 and breast carcinoma.